Track which hedge funds hold Alnylam Pharmaceuticals Inc and how their positions changed over time.
Current Holders
278
Showing
5
| $6.5B |
| 0.9% |
0 |
| FMR LLC | 2025-Q4 | Decreased | 15.9M | -5.2% | $6.3B | 0.3% | 0 |
| VANGUARD GROUP INC | 2025-Q4 | Decreased | 13.6M | -0.1% | $5.4B | 0.1% | 0 |
| BlackRock, Inc. | 2025-Q4 | Increased | 10.4M | +5.0% | $4.1B | 0.1% | 34 |
| Capital Research Global Investors | 2025-Q4 | Decreased | 6.8M | -6.1% | $2.7B | 0.5% | 0 |
Showing 5 of 278 results.PROUpgrade to see all → |
Upgrade to Pro for 2 years of historical data, full analytics access, and CSV exports
Starting at $16/mo billed annually